Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
09/03/2009 | US20090221507 administering peptide sequence tyr-ser-met-lys-lys-thr-thr-met-lys-ile-ile-pro-phe-asn-arg-leu-thr-ile-gly to a mammal to treat degenerative disorder of the nervous system involves leakage of fibrinogen perivascularly in the brain; multiple sclerosis, spinal cord injury, stroke and Alzheimer's Disease |
09/03/2009 | US20090221492 Expression of active human factor ix in mammary tissue of transgenic animals |
09/03/2009 | US20090221483 Antimicrobial Cathelicidin Peptides |
09/03/2009 | US20090221482 Tissue protective peptides and uses thereof |
09/03/2009 | US20090221479 Lgi, lingo and p75ntr family members: novel modulators of neuronal growth |
09/03/2009 | US20090221478 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases |
09/03/2009 | US20090221477 Linkers |
09/03/2009 | US20090221476 Peptide Capable of Altering Tubulin Polymerization and use Thereof for Inhibiting Cell Proliferation |
09/03/2009 | US20090221473 Antitumor agents |
09/03/2009 | US20090221444 Method for Identifying, Marking and Treating Epithelial Lung Tumour Cells and Means for Carrying Out Said Method |
09/03/2009 | US20090221440 Methods and compositions related to identifying protein-protein interactions |
09/03/2009 | US20090221434 Use of particulate labels in bioanalyte detection methods |
09/03/2009 | US20090221077 Process for producing cytotoxic lymphocytes |
09/03/2009 | US20090221076 Method of fabricating sheet for cartilage tissue regeneration |
09/03/2009 | US20090221075 System And Process For Separating A Material |
09/03/2009 | US20090221074 Conductive polymer matrix and device for use in the efficient isolation of preferential stem cells; permits the monitoring of cell binding to the solid matrix during the selection process, it is possible to obtain feedback information on the number of selected cells at any time |
09/03/2009 | US20090221073 Devices and methods for cell manipulation |
09/03/2009 | US20090221072 Compositions and methods for modulating cell differentiation |
09/03/2009 | US20090221071 Polyurea Systems, Processes for Preparing the Same and Use Thereof for Postoperative Adhesion Barriers |
09/03/2009 | US20090221070 In Vitro Production of a Cell Population Using Feeder Cells |
09/03/2009 | US20090221069 Method for augmenting the ability of t-cells and other cells for fighting disease and invade diseased organs, for elevating cd3 zeta and tnf-alpha expression in t-cells, and mixing t-cell boosting and kit particularly useful in such method |
09/03/2009 | US20090221068 Cell Cultivation Method and Cell Culture |
09/03/2009 | US20090221067 Cell lines that express hetero oligomeric taste receptors |
09/03/2009 | US20090221066 Anti-Methylated Dna Antibody and Method for Production Thereof |
09/03/2009 | US20090221040 immunizing an animal with a mixture of different histidine fusion polypeptides and obtaining polyclonal antibodies directed against the histidine portion of the fusion polypeptides from the serum of the animal; rapid |
09/03/2009 | US20090221036 Recombinant anti-cd4 antibodies for human therapy |
09/03/2009 | US20090221035 Systems and methods for protein production |
09/03/2009 | US20090221034 Lipolytic Enzyme Variant With Improved Stability And Polynucleotides Encoding Same |
09/03/2009 | US20090221033 Polypeptides Having Lipase Activity And Polynucleotides Encoding Same |
09/03/2009 | US20090221032 Entropic bristle domain sequences and their use in recombinant protein production |
09/03/2009 | US20090221029 Pfu replication accessory factors and methods of use |
09/03/2009 | US20090221022 Three Dimensional Cell Culture |
09/03/2009 | US20090221016 Modified tumor necrosis factor-alpha converting enzyme and methods of use thereof |
09/03/2009 | US20090221003 Procedure for the generation of a high producer cell line for the expression of a recombinant anti-cd34 antibody |
09/03/2009 | US20090220999 Antibodies immunoreactive with mutant 5-enolpyruvlshikimate-3-phosphate synthase |
09/03/2009 | US20090220991 Reagents for the detection of protein phosphorylation in leukemia signaling pathways |
09/03/2009 | US20090220979 Methods and Apparatus for Magnetic Separation of Cells |
09/03/2009 | US20090220977 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses |
09/03/2009 | US20090220964 Methods for diagnosing and treating cancers via manipulations of a...pathway |
09/03/2009 | US20090220960 Luciferase gene optimized for use in imaging of intracellular luminescence |
09/03/2009 | US20090220959 Markers of definitive endoderm |
09/03/2009 | US20090220933 Detection of fetal cells from maternal blood |
09/03/2009 | US20090220670 Promoter-based silencing |
09/03/2009 | US20090220605 Bone matrix compositions having nanoscale textured surfaces |
09/03/2009 | US20090220595 Combination of erythropoietin glycoisoforms |
09/03/2009 | US20090220569 Prevascularized Constructs for Implantation to Provide Blood Perfusion |
09/03/2009 | US20090220567 Pure Populations of Astrocyte Restricted Precursor Cells and Methods for Isolation and Use Thereof |
09/03/2009 | US20090220565 Method for producing autonomously contracting cardiac muscle cells from adult stem cells, in particular human adult stem cells |
09/03/2009 | US20090220562 Osteogenic and anti-adipogenic oxysterols |
09/03/2009 | US20090220561 Compositions comprising nanostructures for cell, tissue and artificial organ growth, and methods for making and using same |
09/03/2009 | US20090220537 Vaccine delivery system |
09/03/2009 | US20090220534 Methods for identifying t-cell epitopes associated with impaired peptide processing and applications of the identified epitopes |
09/03/2009 | US20090220528 Stimulation of Toll-Like Receptors on T Cells |
09/03/2009 | US20090220527 Affinity optimized epha2 agonistic antibodies and methods of use thereof |
09/03/2009 | US20090220521 Anti MIF Antibodies |
09/03/2009 | US20090220514 ADAM10 and its Uses Related to Infection |
09/03/2009 | US20090220511 human polypeptides named IFN (interferon)- lambda 1, IFN- lambda 2 and IFN- lambda 3 and IFN- lambda R1; antiviral agents |
09/03/2009 | US20090220510 Recognize aberrant glycosylated form of the EGFR; evident upon aberrant post-translational modification; cancer |
09/03/2009 | US20090220504 Combinatorial therapy |
09/03/2009 | US20090220491 Binding agents which inhibit myostatin |
09/03/2009 | US20090220490 Compositions and Assays for Inhibiting HCV Infection |
09/03/2009 | US20090220484 Rage/Diaphanous Interaction and Related Compositions and Methods |
09/03/2009 | US20090220480 Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them |
09/03/2009 | US20090220479 Egln2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart disease |
09/03/2009 | US20090220476 Laglidadg homing endonuclease variants having mutations in two functional subdomains and use thereof |
09/03/2009 | US20090220474 Novel a-galactosidases |
09/03/2009 | US20090220473 Adir related polymorphisms and applications thereof |
09/03/2009 | US20090220472 Method for Treating Malignant Melanoma |
09/03/2009 | US20090220469 Peptides against autoantibodies associated with glaucoma and use of these peptides |
09/03/2009 | US20090220468 Specific CD4+CD25+ Regulatory T Cells for Haematopoietic Cell Transplantation and Immune Tolerance |
09/03/2009 | US20090220467 Use of type ii pneumocytes in the treatment of pulmonary diseases associated with pulmonary fibrosis |
09/03/2009 | US20090220466 Very small embryonic-like (vsel) stem cells and methods of isolating and using the same |
09/03/2009 | US20090220465 Methods and compositions for modulation of stem cell aging |
09/03/2009 | US20090220464 Mesenchymal stem cells and uses therefor |
09/03/2009 | US20090220462 Stem cells |
09/03/2009 | US20090220458 Pseudotyped retroviral vectors and methods of use thereof |
09/03/2009 | US20090220424 Pro104 Antibody Compositions and Methods of Use |
09/03/2009 | CA2717086A1 Mutant gene that regulates oil-and-fat content in seed and method for regulating oil-and-fat content in seed |
09/03/2009 | CA2717083A1 Methods of applying physical stimuli to cells |
09/03/2009 | CA2716609A1 Stem cell expression cassettes |
09/02/2009 | EP2096172A2 Genetic sequences having methyltransferase activity and uses therefor |
09/02/2009 | EP2096169A1 Nuclear reprogramming method |
09/02/2009 | EP2096166A1 Method for production of antibody directed against cell membrane surface antigen epitope and assaying method |
09/02/2009 | EP2096122A1 Anti-human dlk-1 antibody showing anti-tumor activity in vivo |
09/02/2009 | EP2095827A1 High affinity human monoclonal antibodies specific for RSV F-protein |
09/02/2009 | EP2095823A1 GM-CSF for treating demyelination |
09/02/2009 | EP2095127A1 Methods for screening and treatment involving the genes gypc, agpat3, agl, pvrl2, hmgb 3, hsdl2 and/or ldb2 |
09/02/2009 | EP2094839A1 Expansion of hematopoietic stem cells |
09/02/2009 | EP2094838A1 Methods and compositions for differential expansion of fetal cells in maternal blood and their use |
09/02/2009 | EP2094837A2 Use of pi3k m-tor and akt inhibitors to induce foxp3 expression and generate regulatory t cells |
09/02/2009 | EP2094836A2 Generation of inner ear cells |
09/02/2009 | EP2094835A1 Pluripotent cell growth media |
09/02/2009 | EP2094834A2 Pluripotent cells from the mammalian late epiblast layer |
09/02/2009 | EP2094833A2 Differentiation of pluripotent cells into primary germ layer progenitors |
09/02/2009 | EP2094307A2 Tes7 and antibodies that bind thereto |
09/02/2009 | EP2021463A4 Culture method for obtaining a clonal population of antigen-specific b cells |
09/02/2009 | EP1983819A4 Nitrogen-efficient monocot plants |
09/02/2009 | EP1931766A4 Method of culturing conifer somatic embryos using s(+)-abscisic acid |
09/02/2009 | EP1910516A4 Suspension culture of human embryonic stem cells |
09/02/2009 | EP1558278B1 Production of homotrimeric fusion proteins |